| ALS | Amyotrophic lateral sclerosis |
| CNS | Central nerve system |
| CSF | Cerebrospinal fluid |
| CRISPR/SaCas9 | Clustered regularly interspaced short palindromic repeats/CRISPR associated protein 9 from Staphylococcus aureus |
| Ct | Threshold cycle |
| EBNA | Epstein–Barr nuclear antigen |
| EBV | Epstein–Barr virus |
| EDSS | Expanded disability status scale |
| EGF-R | Epidermal growth factor receptor |
| GAPDH | Glyceraldehyde 3-phosphate dehydrogenase |
| HERV | Human endogenous retrovirus |
| kDa | Kilodalton |
| LTR | long terminal repeat region |
| MDM | Monocyte-derived macrophages |
| MS | Multiple sclerosis |
| MSRV | Multiple sclerosis-associated retrovirus |
| NF-κB | Nuclear factor kappa B |
| NK | Natural Killer |
| NO | Neuromyelitis optica |
| PCR | Polymerase chain reaction |
| qPCR | Quantitative PCR |
| RRMS | Relapsing-remitting MS |
| SF2/ASF | Splicing factor 2/alternative splicing factor |
| SPMS | Secondary-progressive MS |
| RT | Reverse transcriptase |
| Tat | Trans activator of transcription |
| TAR | Trans-activation response element |
| TDP-43 | TAR DNA-binding protein 43 |
| TNFα | Tumor necrosis factor-α |